Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis

Clinical and Experimental Immunology

Volumn 163, Issue 2, 2011, Pages 215-224

  Hosomi, S ^a   Oshitani, N ^a   Kamata, N ^a   Sogawa, M ^a   Okazaki, H ^a   Tanigawa, T ^a   Yamagami, H ^a   Watanabe, K ^a   Tominaga, K ^a   Watanabe, T ^a   Fujiwara, Y ^a   Maeda, K ^a   Hirakawa, K ^a   Arakawa, T ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokine; Chemokine receptor; Inflammatory bowel disease; Plasma cell; Ulcerative colitis

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; SYNDECAN 1;

ADULT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ADULT; ANTIGENS, CD19; CELL MOVEMENT; CHEMOKINES; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; INTESTINAL MUCOSA; LYMPHOCYTE COUNT; MIDDLE AGED; PLASMA CELLS; RECEPTORS, CCR; RECEPTORS, CXCR3; RECEPTORS, CXCR4;

EID: 78650845191     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04290.x     Document Type: Article

References (38)

1. Bitton A, Peppercorn MA, Antonioli DA et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001; 120:13-20.
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115:182-205.
3. Yacyshyn BR. Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis. Immunol Cell Biol 1993; 71:265-74.
4. Kett K, Rognum TO, Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 1987; 93:919-24.
5. Hibi T, Ohara M, Toda K et al. In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis. Gut 1990; 31:1371-6.
6. Hibi T, Aiso S, Ishikawa M et al. Circulating antibodies to the surface antigens on colon epithelial cells in ulcerative colitis. Clin Exp Immunol 1983; 54:163-8.
7. Onuma EK, Amenta PS, Ramaswamy K, Lin JJ, Das KM. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5. Clin Exp Immunol 2000; 121:466-71.
8. Ebert EC, Geng X, Bajpai M, Pan Z, Tatar E, Das KM. Antibody to tropomyosin isoform 5 and complement induce the lysis of colonocytes in ulcerative colitis. Am J Gastroenterol 2009; 104:2996-3003.
9. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100:1590-6.
10. Oudkerk Pool M, Ellerbroek PM, Ridwan BU et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993; 34:46-50.
11. Jinno Y, Ohtani H, Nakamura S et al. Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis. Virchows Arch 2006; 448:412-21.
12. Hirata N, Oshitani N, Kamata N et al. Proliferation of immature plasma cells in pouchitis mucosa in patients with ulcerative colitis. Inflamm Bowel Dis 2008; 14:1084-90.
13. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev 2003; 3:822-9.
14. Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001; 2:123-8.
15. Bowman EP, Campbell JJ, Soler D et al. Developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med 2000; 191:1303-18.
16. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2:108-15.
17. Yuan YH, ten Hove T, The FO, Slors JF, van Deventer SJ, te Velde AA. Chemokine receptor CXCR3 expression in inflammatory bowel disease. Inflamm Bowel Dis 2001; 7:281-6.
18. Mikami S, Nakase H, Yamamoto S et al. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis. J Pharmacol Exp Ther 2008; 327:383-92.
19. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317:1625-9.
20. Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-44.
21. Froslie KF, Jahnsen J, Moum BA, Vatn MH. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007; 133:412-22.
22. Harada Y, Kawano MM, Huang N et al. Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 1996; 92:184-91.
23. Noguchi A, Watanabe K, Narumi S et al. The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity. J Gastroenterol 2007; 42:947-56.
24. Gasperini S, Marchi M, Calzetti F et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 1999; 162:4928-37.
25. Jego G, Robillard N, Puthier D et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 1999; 94:701-12.
26. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 1995; 85:487-94.
27. Kawachiya T, Oshitani N, Jinno Y et al. Significance of increased proliferation of immature plasma cells in the appendix of patients with ulcerative colitis. Int J Mol Med 2005; 15:417-23.
28. Henneken M, Dorner T, Burmester GR, Berek C. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2005; 7:R1001-13.
29. Sorensen TL, Roed H, Sellebjerg F. Chemokine receptor expression on B cells and effect of interferon-beta in multiple sclerosis. J Neuroimmunol 2002; 122:125-31.
30. Autschbach F, Giese T, Gassler N et al. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 2002; 441:500-13.
31. Singh UP, Venkataraman C, Singh R, Lillard JW, Jr. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets 2007; 7:111-23.
32. Uguccioni M, Gionchetti P, Robbiani DF et al. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 1999; 155:331-6.
33. Egesten A, Eliasson M, Olin AI et al. The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Int J Colorectal Dis 2007; 22:1421-7.
34. Hargreaves DC, Hyman PL, Lu TT et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001; 194:45-56.
35. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 2003; 170:1136-40.
36. Pabst O, Ohl L, Wendland M et al. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J Exp Med 2004; 199:411-16.
37. Kunkel EJ, Kim CH, Lazarus NH et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003; 111:1001-10.
38. Hardi R, Mayer L, Targan SR, Yellin M, Cardarelli PM, Das KM. A phase 1 open-label, single-dose, dose-escalation study of Mdx-1100, a high-affinity, neutralizing, fully human Igg1 kappa anti-CXCL10 (Ip10) monoclonal antibody, in ulcerative colitis. Gastroenterology 2008; 134:A99-A100.